BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Aptamer Group's Optimer-Fc: An Innovative Solution to Enhance Accuracy of Automated IHC Workflows

Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...

March 29, 2023 | Influencers

Eppendorf's commitment to customer-centric innovation: How the company stays ahead of the curve

BioPharma APAC organized a Women’s Leadership Series and interviewed a Eva van Pelt Co-CEO & Chief Commercial Officer Eppendorf SE, Hamburg, Germ...

March 21, 2023 | News

New Medium and Feeds System from Thermo Fisher Scientific Boosts CHO Cell Culture Performance

Thermo Fisher Scientific, a leading biotechnology company, recently provided expert insights into its new media and feed system, Gibco™ Effic...

March 21, 2023 | News

BRIM appoints Andrew Lin as Chairman and Dr. Wen Chyi Shyu as CEO, secures $18M in Series E funding, and advances clinical trials for Dry Eye Disease and Neurotrophic Keratitis treatments

What led to the decision to elect Andrew Lin as the new Chairman of the Board, and how do you believe he will contribute to BRIM's continued succ...

March 01, 2023 | Opinion

Oliver Healthcare Packaging expands presence in Asia Pacific with new manufacturing facility in Malaysia

Oliver Healthcare Packaging has announced plans to expand its presence in Asia Pacific with a new manufacturing facility in Malaysia, which is set to open ...

March 01, 2023 | Opinion

Emerson Experts Discuss the Benefits of Digitalization in the Life Sciences Industry

How can digitalization help improve the efficiency and speed of drug development in the life sciences industry? Michalle Adkins: Techn...

February 27, 2023 | Influencers

STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option

Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...

February 13, 2023 | News

GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

How is GenScript planning to meet the growing demand for cell and gene therapies in 2023? GenScript is committed to advancing non-viral gene and cell ther...

February 01, 2023 | Influencers

Aptamer Group’s discovery platform is enabling new solutions across the life sciences.

How is success in the discovery of small molecule ligands increased with the Optimer platform? The Optimer platform incorporates three se...

January 04, 2023 | News

Process design and modular facilities to advance sustainability in biomanufacturing

A growing bulk of this demand comes from biologics which have become the mainstay of treatment methods from cancer to autoimmune disorder to viral infectio...

August 15, 2022 | Opinion | By Francis Van Parys, Vice President (Commercial) APAC at Cytiva

" Our partnerships with both NGS & TGS technology giants have facilitated the world’s most comprehensive populations genomics initiative, enabling us to provide cost-effective, high-accuracy sequencing at scale " : Ashish Koshy

What are the major plans in store for G42 Healthcare? Any new segments to be explored? G42 Healthcare is transforming the traditional he...

June 28, 2022 | News

" We are seeing a growing need for contract research organizations (CROs), pharmaceutical companies and regulators in APAC for access to the bioanalysis training needed to conduct drug equivalence tests for the approval of generic drugs " : David Curtin

What are the current opportunities and challenges at Waters ? There is a lot of activity with pharma contract organizations in Asia. F...

June 27, 2022 | Influencers

Technology as an ally to healthcare: How tech solutions can help democratise treatments and relieve the pressure on health systems

Today, every child knows how to run a computer and its capabilities have developed dramatically. In fact, between traditional PCs, laptops, phones, tablets...

February 22, 2022 | Influencers | By Dr. Angelica Kohlmann, Co-founder of Bloom Diagnostics

Thermo Fisher Scientific is responding by increasing capacity and diversifying into new geographies and innovative therapies

1) What strategic changes have you brought about within the business due to COVID-19? Essential to Thermo Fisher Scientific’s ability to support bi...

November 12, 2021 | Influencers

Stay Connected